HIPAA Alert: Potential Data Breach Learn More

Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic

844-346-7222
Request Appointment
Search
Close this search box.
844-346-7222
REQUEST AN APPOINTMENT

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

We’re here for you. Call us at 844-346-7222 or

request an appointment online

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

1 Clinical Trials
Chronic Lymphocytic Leukemia Phase II Enrolling
nct/study# 4895436 / M20-356

A Multicenter, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Venetoclax-Obinutuzumab Retreatment in Patients with Recurring Chronic Lymphocytic Leukemia

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Request An Appointment
Community Oncology Alliance Logo
COA Patient Advocacy Network Logo
OncLive® Strategic Alliance Partner Badge
Pharmacy Times® Strategic Alliance Partner Badge
Targeted Oncology Strategic Alliance Partner Badge

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.